Skip to main content
Close modal button

The information
contained in this section of the site is clinical in nature and specifically created for healthcare professionals. If you are not a US healthcare professional, please click CLOSE to return to the consumer section of the site.

Yes, I am a US healthcare professional and would like to continue.

CONTINUEContinue to healthcare professional site
For US Healthcare ProfessionalsOpen Modal Button

Full Prescribing
Information

  • Home
  • About TYVASO
  • Starting TYVASO
  • TYVASO RESOURCES

    • ISI Icon
    IMPORTANT SAFETY INFORMATION

    Before you take TYVASO, tell your healthcare provider about all of your medical conditions, including if you:

    • Have lung disease, such as asthma or chronic obstructive pulmonary disease (COPD)
    • Have a lung infection

    ISI Icon
    IMPORTANT SAFETY INFORMATION

    Before you take TYVASO, tell your healthcare provider about all of your medical conditions, including if you:

    • Have lung disease, such as asthma or chronic obstructive pulmonary disease (COPD)
    • Have a lung infection
    • Have liver or kidney problems
    • Have low blood pressure
    • Have bleeding problems
    • Are pregnant or plan to become pregnant. It is not known if TYVASO will harm your unborn baby.
    • Are breast-feeding or plan to breast-feed. It is not known if TYVASO passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with TYVASO.

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TYVASO and other medicines may affect each other.

    Especially tell your healthcare provider if you take:

    • Medicines used to treat high blood pressure or heart disease
    • Medicines that decrease blood clotting (anticoagulants)
    • Water pills (diuretics)
    • Gemfibrozil (Lopid) or rifampin (Rimactane, Rifadin, Rifamate, Rifater)
    What are the possible side effects of TYVASO?

    TYVASO can cause serious side effects, including:

    • Low blood pressure (symptomatic hypotension). If you have low blood pressure, TYVASO may lower your blood pressure more.
    • Bleeding problems. TYVASO may increase the risk of bleeding, especially in people who take blood thinners (anticoagulants).

    The most common side effects of TYVASO are cough, headache, throat irritation and pain, nausea, reddening of the face and neck (flushing), fainting or loss of consciousness, dizziness, and diarrhea. These are not all the possible side effects of TYVASO. Call your doctor for medical advice about side effects.

    You may report side effects to the FDA at

    You are now leaving the Tyvaso.com website

    This link will take you to a site maintained by a third party who is solely responsible for the site's content. Click CONTINUE to proceed or CLOSE to return to Tyvaso.com.

    CONTINUE
    www.fda.gov/MedWatch
    or call 1-800-FDA-1088.

    What is TYVASO?

    TYVASO (treprostinil) is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. TYVASO can improve the ability to exercise. Your ability to exercise decreases 4 hours after taking TYVASO. It is not known if TYVASO is safe and effective in children under 18 years of age.

    The risk information provided here is not comprehensive. To learn more about TYVASO, talk with your healthcare provider. Please see Full Prescribing Information, Patient Product Information, and the TD-100 and TD-300 TYVASO® Inhalation System Instructions for Use manuals at www.tyvaso.com or call 1-877-UNITHER (1-877-864-8437).

    TYVISIconOct19

    WHO=World Health Organization.

    This site is intended for
    use by US residents only.

    TYVASO is a registered trademark of United Therapeutics Corporation.

    All other brands are trademarks of their respective owners. The makers of these brands are not affiliated with United Therapeutics or its products.

    ©2020 United Therapeutics Corporation. All rights reserved. US-TYV-0414